Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4FMFES-PET for ER+ Endometrial and Ovarian Cancers
NCT04823065Phase 2Completed
- Sponsor
- Centre de recherche du CHUS
- Start
- Sep 2018
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-4FMFES in endometrial cancer (EC), ovarian cancer, sponsored by Centre de recherche du CHUS. Started Sep 2018; status: completed.
02
Drugs
18F-4FMFES
03
Conditions
endometrial cancer (EC)ovarian cancer
Beyond the preview
Go deeper on NCT04823065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04823065.